本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

20.08
+0.64003.29%
成交量:123.36万
成交额:2,488.47万
市值:25.24亿
市盈率:-11.18
高:20.59
开:19.58
低:19.25
收:19.44
数据加载中...
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/01

重要事件披露

Form 8-K - Current report
2023/11/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report